Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McLachlan

Showing results (61-70 of 497) with videos related to

Pageof 50
Sort By:
Statistical Methods in Medical Research|July 12, 2019
Mixture cure models with time-varying and multilevel frailties for recurrent event dataRichard Tawiah, Geoffrey J McLachlan, Shu Kay Ng
CPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation StudyJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Current Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlan
Current Gerontology and Geriatrics Research|August 17, 2011
Clinical pharmacology of chemotherapy agents in older people with cancerXiaoye He, Stephen J Clarke, Andrew J McLachlan
Expert Opinion on Drug Metabolism & Toxicology|August 5, 2017
Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactionsJeffry Adiwidjaja, Andrew J McLachlan, Alan V Boddy
British Journal of Clinical Pharmacology|October 19, 2020
A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteersAdele Hosseini, Andrew J McLachlan, Jason D Lickliter
European Journal of Clinical Pharmacology|January 20, 2022
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinibJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
The Journal of Pharmacy and Pharmacology|February 8, 2018
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin contentSigrun Chrubasik-Hausmann, Julia Vlachojannis, Andrew J McLachlan
Bioinformatics (Oxford, England)|December 15, 2006
Segmentation and intensity estimation of microarray images using a gamma-t mixture modelJangsun Baek, Young Sook Son, Geoffrey J McLachlan
Biotechnology and Bioengineering|July 7, 2007
Further improvement of phosphite dehydrogenase thermostability by saturation mutagenesisMichael J McLachlan, Tyler W Johannes, Huimin Zhao
Pageof 50

Showing results (61-70 of 497) with videos related to

Sort By:
Pageof 50
Statistical Methods in Medical Research|July 12, 2019
Mixture cure models with time-varying and multilevel frailties for recurrent event dataRichard Tawiah, Geoffrey J McLachlan, Shu Kay Ng
CPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation StudyJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Current Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlan
Current Gerontology and Geriatrics Research|August 17, 2011
Clinical pharmacology of chemotherapy agents in older people with cancerXiaoye He, Stephen J Clarke, Andrew J McLachlan
Expert Opinion on Drug Metabolism & Toxicology|August 5, 2017
Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactionsJeffry Adiwidjaja, Andrew J McLachlan, Alan V Boddy
British Journal of Clinical Pharmacology|October 19, 2020
A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteersAdele Hosseini, Andrew J McLachlan, Jason D Lickliter
European Journal of Clinical Pharmacology|January 20, 2022
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinibJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
The Journal of Pharmacy and Pharmacology|February 8, 2018
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin contentSigrun Chrubasik-Hausmann, Julia Vlachojannis, Andrew J McLachlan
Bioinformatics (Oxford, England)|December 15, 2006
Segmentation and intensity estimation of microarray images using a gamma-t mixture modelJangsun Baek, Young Sook Son, Geoffrey J McLachlan
Biotechnology and Bioengineering|July 7, 2007
Further improvement of phosphite dehydrogenase thermostability by saturation mutagenesisMichael J McLachlan, Tyler W Johannes, Huimin Zhao
Pageof 50